Spruce Biosciences (SPRB) Climbs 25% Following $15 Price Target at Oppenheimer
Spruce Biosciences (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
